BRPI0920434A2 - tratamento sistêmico de parasitas consumidores ou sugadores de sangue pela administração oral de um agente parasiticidal. - Google Patents

tratamento sistêmico de parasitas consumidores ou sugadores de sangue pela administração oral de um agente parasiticidal.

Info

Publication number
BRPI0920434A2
BRPI0920434A2 BRPI0920434A BRPI0920434A BRPI0920434A2 BR PI0920434 A2 BRPI0920434 A2 BR PI0920434A2 BR PI0920434 A BRPI0920434 A BR PI0920434A BR PI0920434 A BRPI0920434 A BR PI0920434A BR PI0920434 A2 BRPI0920434 A2 BR PI0920434A2
Authority
BR
Brazil
Prior art keywords
sucking
blood
oral administration
systemic treatment
parasiticidal agent
Prior art date
Application number
BRPI0920434A
Other languages
English (en)
Inventor
Douglas I Hepler
Kathleen G Palma
Roland H Johnson
William R Campbell
Original Assignee
Bayer Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Bv filed Critical Bayer Bv
Publication of BRPI0920434A2 publication Critical patent/BRPI0920434A2/pt
Publication of BRPI0920434B1 publication Critical patent/BRPI0920434B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0920434-2A 2008-10-03 2009-09-30 Composição farmaceuticamente aceitável com uma quantidade ectoparasiticidamente eficaz de imidacloprid para administração oral em mamíferos BRPI0920434B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10277408P 2008-10-03 2008-10-03
US61/102,774 2008-10-03
PCT/US2009/059111 WO2010039892A1 (en) 2008-10-03 2009-09-30 Systemic treatment of blood-sucking and blood-consuming parasites oral administration of a parasiticidal agent

Publications (2)

Publication Number Publication Date
BRPI0920434A2 true BRPI0920434A2 (pt) 2015-12-22
BRPI0920434B1 BRPI0920434B1 (pt) 2021-07-27

Family

ID=42073871

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920434-2A BRPI0920434B1 (pt) 2008-10-03 2009-09-30 Composição farmaceuticamente aceitável com uma quantidade ectoparasiticidamente eficaz de imidacloprid para administração oral em mamíferos

Country Status (29)

Country Link
US (2) US9820977B2 (pt)
EP (1) EP2349265B1 (pt)
JP (3) JP6110065B2 (pt)
KR (3) KR20110067048A (pt)
CN (2) CN107041887A (pt)
AU (1) AU2009298541B2 (pt)
BR (1) BRPI0920434B1 (pt)
CA (1) CA2736263C (pt)
CL (1) CL2011000713A1 (pt)
CO (1) CO6361913A2 (pt)
DK (1) DK2349265T3 (pt)
EC (1) ECSP11011023A (pt)
ES (1) ES2588152T3 (pt)
HR (1) HRP20161082T1 (pt)
HU (1) HUE030412T2 (pt)
IL (1) IL211624B (pt)
MX (1) MX2011003415A (pt)
NI (1) NI201100067A (pt)
NZ (1) NZ592010A (pt)
PE (1) PE20110395A1 (pt)
PH (1) PH12011500679A1 (pt)
PL (1) PL2349265T3 (pt)
PT (1) PT2349265T (pt)
RU (1) RU2526169C2 (pt)
SI (1) SI2349265T1 (pt)
SV (1) SV2011003871A (pt)
UA (1) UA102565C2 (pt)
WO (1) WO2010039892A1 (pt)
ZA (1) ZA201102077B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP3517A (en) * 2010-04-22 2016-01-11 Genesis Lab Inc Compositions and methods for control of sand flies and other blood sucking insects.
US20120321703A1 (en) * 2011-06-16 2012-12-20 Daniel Kouri Capsule for oral pet medicine
EP2833866B2 (en) 2012-04-04 2024-11-27 Intervet International B.V. Soft chewable pharmaceutical products
US9504656B2 (en) * 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
WO2017106812A1 (en) 2015-12-19 2017-06-22 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
UY40429A (es) 2016-02-24 2023-10-13 Boehringer Ingelheim Animal Health Usa Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
MX2019005040A (es) * 2016-10-31 2019-10-30 Tropiq Health Sciences Métodos y composiciones para prevenir la transmisión de enfermedades vectoriales.
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
US12269822B2 (en) 2018-07-09 2025-04-08 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic heterocyclic compounds
WO2020112374A1 (en) 2018-11-20 2020-06-04 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
MX2021011302A (es) 2019-03-19 2022-01-19 Boehringer Ingelheim Animal Health Usa Inc Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos.
KR102659363B1 (ko) 2020-05-26 2024-04-22 주식회사 경보제약 동물에서의 기생충 감염 질환을 치료 또는 예방하기 위한 수의학적 구강붕해필름 제제
KR20230028268A (ko) 2020-05-29 2023-02-28 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 헤테로시클릭 화합물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4419814A1 (de) * 1994-06-07 1995-12-14 Bayer Ag Endoparasitizide
US6140350A (en) 1998-06-08 2000-10-31 Sumitomo Chemical Company, Limited Method for controlling ectoparasites
JP4538863B2 (ja) * 1998-06-08 2010-09-08 住友化学株式会社 寄生虫の駆除方法
JP2000062271A (ja) 1998-08-17 2000-02-29 Murata Mach Ltd 記録装置
DE122011100022I1 (de) 1999-08-12 2011-10-20 Lilly Co Eli Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad.
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
JP4972843B2 (ja) 2000-11-09 2012-07-11 住友化学株式会社 動物外部寄生虫防除用経皮投与剤
CN1386420A (zh) 2001-05-22 2002-12-25 王玉万 一种含吡虫啉的宠物用抗寄生虫药
UA80096C2 (en) 2001-07-05 2007-08-27 Mikkel Sa Fencing for preventing insects to enter
MXPA04006002A (es) 2001-12-21 2004-09-27 Rhodia Composiciones tensioactivas estables para suspender componentes.
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US7648711B2 (en) 2003-05-25 2010-01-19 Yuwan Wang Dimethicone-containing sustained release injection formulation
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
US20050234119A1 (en) 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
MX2007005617A (es) 2004-11-11 2007-07-09 Merial Ltd Derivados de vinilaminopirazol como pesticidas.
UY28617A1 (es) * 2004-11-12 2006-06-30 Popley Pharma Ltda Nuevas composiciones
MX2007008837A (es) 2005-01-21 2008-01-22 Merial Ltd Compuestos quimicos, procesos para su preparacion y uso de los mismos.
TWI412322B (zh) * 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
US7919522B2 (en) * 2007-05-03 2011-04-05 Merial Limited Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds

Also Published As

Publication number Publication date
SV2011003871A (es) 2011-08-22
CA2736263C (en) 2020-01-14
US20100087492A1 (en) 2010-04-08
UA102565C2 (ru) 2013-07-25
JP2016179983A (ja) 2016-10-13
JP6388890B2 (ja) 2018-09-12
CO6361913A2 (es) 2012-01-20
KR20110067048A (ko) 2011-06-20
NI201100067A (es) 2012-03-15
HUE030412T2 (hu) 2017-05-29
PH12011500679A1 (en) 2012-11-12
US20180078537A1 (en) 2018-03-22
AU2009298541B2 (en) 2015-03-26
US9820977B2 (en) 2017-11-21
EP2349265A4 (en) 2012-10-24
EP2349265A1 (en) 2011-08-03
PT2349265T (pt) 2016-08-31
NZ592010A (en) 2012-07-27
MX2011003415A (es) 2011-08-12
WO2010039892A1 (en) 2010-04-08
HRP20161082T1 (hr) 2016-10-21
BRPI0920434B1 (pt) 2021-07-27
RU2526169C2 (ru) 2014-08-20
CN107041887A (zh) 2017-08-15
SI2349265T1 (sl) 2016-10-28
ES2588152T3 (es) 2016-10-31
RU2011117203A (ru) 2012-11-10
ZA201102077B (en) 2012-12-27
IL211624A0 (en) 2011-05-31
ECSP11011023A (es) 2011-06-30
KR101903313B1 (ko) 2018-10-01
JP2012504636A (ja) 2012-02-23
JP6110065B2 (ja) 2017-04-05
CL2011000713A1 (es) 2011-08-26
WO2010039892A8 (en) 2011-03-24
JP2018127468A (ja) 2018-08-16
PL2349265T3 (pl) 2017-01-31
KR20170118235A (ko) 2017-10-24
KR101787917B1 (ko) 2017-10-18
KR20160011711A (ko) 2016-02-01
PE20110395A1 (es) 2011-06-19
IL211624B (en) 2018-01-31
CA2736263A1 (en) 2010-04-08
EP2349265B1 (en) 2016-05-25
CN102170880A (zh) 2011-08-31
AU2009298541A1 (en) 2010-04-08
DK2349265T3 (en) 2016-09-05

Similar Documents

Publication Publication Date Title
BRPI0920434A2 (pt) tratamento sistêmico de parasitas consumidores ou sugadores de sangue pela administração oral de um agente parasiticidal.
NL301256I2 (nl) cedazuridine, of een farmaceutisch aanvaardbaar zout daarvan
NL300990I1 (nl) Brigatinib, dan wel een farmaceutisch aanvaardbaar zout daarvan
NL300886I2 (nl) baricitinib, of een farmaceutisch aanvaardbaar zout daarvan
PL2237739T3 (pl) Wiertło do podnoszenia śluzówki dna zatoki
CL2008000461A1 (es) Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos.
SMT201300007B (it) Trattamento di una malattia respiratoria
IL246697B (en) Multiple exon skipping compositions for use in treating muscular dystrophy
HUS1600048I1 (hu) Készítmény Fabry-kór kezelésére
BRPI0815773A2 (pt) composto, e, medicamento.
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
BRPI0810646A2 (pt) " compostos farmacêuticos ".
DK2381988T3 (da) Medikamentadministrationsanordning
HUE062920T2 (hu) Eljárások vakcina beadására
EP2310363A4 (en) ORAL ANTIBODY FORMULATIONS
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
DK2018158T3 (da) Ny racecadotril administrationsform
EP1988823A4 (en) SLOW INTRAVENTUAL RELEASE
BRPI0913613A2 (pt) composto, medicamento, e, agente antagonizante do receptor sensível a cálcio
EP2052757A4 (en) MEDICAL CAPSULE
BRPI0919694A2 (pt) composto, composto farmacêutica, uso de um composto, e, método de tratamento de uma doença.
EE200900024A (et) Meetod 3-(2,2,2-trimetlhdrasiinium)propionaadi dihdraadi valmistamiseks
BRPI0922888A2 (pt) administração combinada de fármaco
BRPI0911969A2 (pt) quinazolinas substituídas como agente de redução de plaquetas sanguíneas.
BRPI0820210A2 (pt) composto, composição farmacêutica, uso de um composto, e, método de tratamento terapêutico de um mamífero.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/09/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.